Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Langel

Showing results (91-100 of 565) with videos related to

Pageof 57
Sort By:
Advanced Drug Delivery Reviews|November 30, 2007
Predicting cell-penetrating peptidesMats Hansen, Kalle Kilk, Ulo Langel
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2021
Tissue Analysis of Lung-Targeted Delivery of siRNA and Plasmid DNAKaido Kurrikoff, Birgit Vunk, Ülo Langel
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2021
CRISPR/Cas9 Plasmid Delivery Through the CPP: PepFect14Luca Falato, Birgit Vunk, Ülo Langel
Pharmaceutics|February 25, 2023
In Silico Studies to Support Vaccine DevelopmentLeonor Saldanha, Ülo Langel, Nuno Vale
Neuropeptides|September 1, 1995
Metabolism of galanin and galanin (1-16) in isolated cerebrospinal fluid and spinal cord membranes from ratK Bedecs, U Langel, T Bartfai
Virus Research|February 2, 2000
Inhibition of the bovine papillomavirus E2 protein activity by peptide nucleic acidR Kurg, U Langel, M Ustav
Analytical Biochemistry|June 7, 2015
Optimized luciferase assay for cell-penetrating peptide-mediated delivery of short oligonucleotidesHenrik Helmfors, Jonas Eriksson, Ülo Langel
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2015
SCARA Involvement in the Uptake of Nanoparticles Formed by Cell-Penetrating PeptidesHenrik Helmfors, Staffan Lindberg, Ülo Langel
Trends in Pharmacological Sciences|August 1, 1992
Galanin and galanin antagonists: molecular and biochemical perspectivesT Bartfai, G Fisone, U Langel
Neuropeptides|February 13, 2001
Galanin receptor subtypes and ligand bindingA Florén, T Land, U Langel
Pageof 57

Showing results (91-100 of 565) with videos related to

Sort By:
Pageof 57
Advanced Drug Delivery Reviews|November 30, 2007
Predicting cell-penetrating peptidesMats Hansen, Kalle Kilk, Ulo Langel
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2021
Tissue Analysis of Lung-Targeted Delivery of siRNA and Plasmid DNAKaido Kurrikoff, Birgit Vunk, Ülo Langel
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2021
CRISPR/Cas9 Plasmid Delivery Through the CPP: PepFect14Luca Falato, Birgit Vunk, Ülo Langel
Pharmaceutics|February 25, 2023
In Silico Studies to Support Vaccine DevelopmentLeonor Saldanha, Ülo Langel, Nuno Vale
Neuropeptides|September 1, 1995
Metabolism of galanin and galanin (1-16) in isolated cerebrospinal fluid and spinal cord membranes from ratK Bedecs, U Langel, T Bartfai
Virus Research|February 2, 2000
Inhibition of the bovine papillomavirus E2 protein activity by peptide nucleic acidR Kurg, U Langel, M Ustav
Analytical Biochemistry|June 7, 2015
Optimized luciferase assay for cell-penetrating peptide-mediated delivery of short oligonucleotidesHenrik Helmfors, Jonas Eriksson, Ülo Langel
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2015
SCARA Involvement in the Uptake of Nanoparticles Formed by Cell-Penetrating PeptidesHenrik Helmfors, Staffan Lindberg, Ülo Langel
Trends in Pharmacological Sciences|August 1, 1992
Galanin and galanin antagonists: molecular and biochemical perspectivesT Bartfai, G Fisone, U Langel
Neuropeptides|February 13, 2001
Galanin receptor subtypes and ligand bindingA Florén, T Land, U Langel
Pageof 57